DarioHealth Corp
NASDAQ:DRIO
Intrinsic Value
DarioHealth Corp. is a digital therapeutics company, which engages in the research, development, and sale of pharmaceutical products. [ Read More ]
The intrinsic value of one DRIO stock under the Base Case scenario is 6.21 USD. Compared to the current market price of 1.47 USD, DarioHealth Corp is Undervalued by 76%.
Valuation Backtest
DarioHealth Corp
Run backtest to discover the historical profit from buying and selling DRIO stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
DarioHealth Corp
Current Assets | 47.3m |
Cash & Short-Term Investments | 37.1m |
Receivables | 5.2m |
Other Current Assets | 5.1m |
Non-Current Assets | 49.1m |
PP&E | 1.9m |
Intangibles | 47m |
Other Non-Current Assets | 149k |
Current Liabilities | 12.5m |
Accounts Payable | 7.4m |
Accrued Liabilities | 111k |
Other Current Liabilities | 5m |
Non-Current Liabilities | 25.8m |
Long-Term Debt | 24.6m |
Other Non-Current Liabilities | 1.2m |
Earnings Waterfall
DarioHealth Corp
Revenue
|
20.4m
USD
|
Cost of Revenue
|
-14.4m
USD
|
Gross Profit
|
6m
USD
|
Operating Expenses
|
-62.2m
USD
|
Operating Income
|
-56.2m
USD
|
Other Expenses
|
-7.3m
USD
|
Net Income
|
-63.5m
USD
|
Free Cash Flow Analysis
DarioHealth Corp
DRIO Profitability Score
Profitability Due Diligence
DarioHealth Corp's profitability score is 26/100. The higher the profitability score, the more profitable the company is.
Score
DarioHealth Corp's profitability score is 26/100. The higher the profitability score, the more profitable the company is.
DRIO Solvency Score
Solvency Due Diligence
DarioHealth Corp's solvency score is 45/100. The higher the solvency score, the more solvent the company is.
Score
DarioHealth Corp's solvency score is 45/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
DRIO Price Targets Summary
DarioHealth Corp
According to Wall Street analysts, the average 1-year price target for DRIO is 5.78 USD with a low forecast of 4.04 USD and a high forecast of 8.4 USD.
Ownership
DRIO Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
DRIO Price
DarioHealth Corp
Average Annual Return | 0.04% |
Standard Deviation of Annual Returns | 95.07% |
Max Drawdown | -97% |
Market Capitalization | 40m USD |
Shares Outstanding | 29 442 500 |
Percentage of Shares Shorted | 5.19% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
DarioHealth Corp. is a digital therapeutics company, which engages in the research, development, and sale of pharmaceutical products. The company is headquartered in New York City, New York and currently employs 200 full-time employees. The company went IPO on 2013-03-08. DarioHealth operates at the intersection of life sciences, behavioral science, and software technology to deliver integrated and engaging digital therapeutics interventions. DarioHealth offers digital therapeutics solutions covering multiple chronic conditions including diabetes, hypertension, weight management, musculoskeletal and behavioral health within one integrated technology platform. Its products include Dario Blood Glucose Monitoring Starter Kit and Dario Blood Pressure Monitoring System. Its Dario Blood Glucose Monitoring Starter Kit is pocket-sized smartphone blood glucose meter that measure sugar levels. Its Dario Blood Pressure Monitoring System is a blood pressure monitoring system used to measure blood pressure, which allows to store all your readings in the Dario App. Its Dario mobile application, the Dario Blood sugar (glucose) meter enables to track and check blood sugar (glucose) in real-time.
Contact
IPO
Employees
Officers
The intrinsic value of one DRIO stock under the Base Case scenario is 6.21 USD.
Compared to the current market price of 1.47 USD, DarioHealth Corp is Undervalued by 76%.